Literature DB >> 1900873

Cross-linking of surface Ig receptors on murine B lymphocytes stimulates the expression of nuclear tetradecanoyl phorbol acetate-response element-binding proteins.

T C Chiles1, J L Liu, T L Rothstein.   

Abstract

Cross-linking of sIg on primary B lymphocytes leads to increased nuclear DNA-binding activity specific for the tetradecanoyl phorbol acetate-response element (TRE), as judged by gel mobility shift assays. Stimulation of B cells to enter S phase of the cell cycle by treatment with the combination of phorbol ester plus calcium ionophore also stimulated nuclear TRE-binding activity within 2 h, with maximal expression at 4 h; however, phorbol ester and calcium ionophore were not as effective in stimulating binding activity when examined separately. Stimulated nuclear expression of TRE-binding activity appears to require protein synthesis. Fos- and Jun/AP-1-related proteins participate directly in the identified nucleoprotein complex, as shown by the ability of c-fos- and c-jun-specific antisera to either alter or completely abolish electrophoretic migration of the complex in native gels. Further, UV photo-cross-linking studies identified two major TRE-binding protein species, whose sizes correspond to TRE-binding proteins derived from HeLa cell nuclear extracts. The results suggest that in primary B cells nuclear TRE-binding activity represents a "downstream" signaling event that occurs subsequent to changes in protein kinase C activity and intracellular Ca2+ but that can be triggered "physiologically" through sIg.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1900873

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  12 in total

1.  A ternary complex factor-dependent mechanism mediates induction of egr-1 through selective serum response elements following antigen receptor cross-linking in B lymphocytes.

Authors:  S B McMahon; J G Monroe
Journal:  Mol Cell Biol       Date:  1995-02       Impact factor: 4.272

2.  Role of EGR1 in regulation of stimulus-dependent CD44 transcription in B lymphocytes.

Authors:  J S Maltzman; J A Carman; J G Monroe
Journal:  Mol Cell Biol       Date:  1996-05       Impact factor: 4.272

3.  The LMP2A ITAM is essential for providing B cells with development and survival signals in vivo.

Authors:  M Merchant; R G Caldwell; R Longnecker
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

4.  Regulation of alpha-fetoprotein expression by Nkx2.8.

Authors:  Yasuo Kajiyama; Jianmin Tian; Joseph Locker
Journal:  Mol Cell Biol       Date:  2002-09       Impact factor: 4.272

5.  A promoter-linked coupling region required for stimulation of alpha-fetoprotein transcription by distant enhancers.

Authors:  P Wen; N Crawford; J Locker
Journal:  Nucleic Acids Res       Date:  1993-04-25       Impact factor: 16.971

6.  B cell receptor crosstalk: B cells express osteopontin through the combined action of the alternate and classical BCR signaling pathways.

Authors:  Benchang Guo; Joseph R Tumang; Thomas L Rothstein
Journal:  Mol Immunol       Date:  2008-10-25       Impact factor: 4.407

7.  Sphingosylphosphocholine, a signaling molecule which accumulates in Niemann-Pick disease type A, stimulates DNA-binding activity of the transcription activator protein AP-1.

Authors:  A Berger; D Rosenthal; S Spiegel
Journal:  Proc Natl Acad Sci U S A       Date:  1995-06-20       Impact factor: 11.205

8.  Induction of bcl-2 expression by phosphorylated CREB proteins during B-cell activation and rescue from apoptosis.

Authors:  B E Wilson; E Mochon; L M Boxer
Journal:  Mol Cell Biol       Date:  1996-10       Impact factor: 4.272

9.  A novel hepatocytic transcription factor that binds the alpha-fetoprotein promoter-linked coupling element.

Authors:  P Wen; J Locker
Journal:  Mol Cell Biol       Date:  1994-10       Impact factor: 4.272

10.  A novel gene coding for a Fas apoptosis inhibitory molecule (FAIM) isolated from inducibly Fas-resistant B lymphocytes.

Authors:  T J Schneider; G M Fischer; T J Donohoe; T P Colarusso; T L Rothstein
Journal:  J Exp Med       Date:  1999-03-15       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.